文献速递放射性药物与辐射防护

MIRD手册第28部分第2篇:在诊断性放射性药物汇编中比较评估MIRDcalc剂量学软件

MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals.
PubMed 文献 · J Nucl Med · 2023-06-02

该研究从国际放射防护委员会(ICRP)第128号出版物获取约70种现用及曾用放射性药物的生物动力学数据,用MIRDcalc、IDAC-Dose和OLINDA软件计算吸收剂量与有效剂量系数,并将MIRDcalc结果与其他软件及ICRP第128号出版物原值系统比较。MIRDcalc与IDAC-Dose总体一致性极好,其他软件及ICRP第128号出版物数值与MIRDcalc结果均处于合理一致范围。

要点

  • 约70种诊断性放射性药物的剂量系数经MIRDcalc、IDAC-Dose与OLINDA三种软件计算并相互比较。
  • MIRDcalc与IDAC-Dose计算的剂量系数总体一致性极好。
  • 其他软件及ICRP第128号出版物数值与MIRDcalc结果均处于合理一致范围。

核心结论

  • MIRDcalc与IDAC-Dose计算的剂量系数总体一致性极好,其他软件及ICRP第128号出版物数值与MIRDcalc结果均处于合理一致范围。

研究设计与样本

  • 从ICRP第128号出版物获取约70种现用及曾用放射性药物的生物动力学数据,用MIRDcalc、IDAC-Dose和OLINDA软件计算吸收剂量与有效剂量系数,并将MIRDcalc结果与其他软件及ICRP第128号出版物原值系统比较。

主要发现

  • MIRDcalc与IDAC-Dose计算的剂量系数总体一致性极好。
  • 其他软件计算的剂量系数与ICRP第128号出版物公布的剂量系数均与MIRDcalc计算的剂量系数处于合理一致范围。

关键数值与推荐

  • 生物动力学数据来源于ICRP第128号出版物放射性药物数据汇编,涵盖约70种现用及曾用放射性药物。
  • 剂量系数包括吸收剂量系数与有效剂量系数,分别由MIRDcalc、IDAC-Dose和OLINDA软件导出。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出未来工作应扩大验证范围以纳入个体化剂量学计算。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radiopharmaceutical dosimetry is usually estimated via organ-level MIRD schema-style formalisms, which form the computational basis for commonly used clinical and research dosimetry software. Recently, MIRDcalc internal dosimetry software was developed to provide a freely available organ-level dosimetry solution that incorporates up-to-date models of human anatomy, addresses uncertainty in radiopharmaceutical biokinetics and patient organ masses, and offers a 1-screen user interface as well as quality assurance tools. The present work describes the validation of MIRDcalc and, secondarily, provides a compendium of radiopharmaceutical dose coefficients obtained with MIRDcalc. Biokinetic data for about 70 currently and historically used radiopharmaceuticals were obtained from the International Commission on Radiological Protection (ICRP) publication 128 radiopharmaceutical data compendium. Absorbed dose and effective dose coefficients were derived from the biokinetic datasets using MIRDcalc, IDAC-Dose, and OLINDA software. The dose coefficients obtained with MIRDcalc were systematically compared against the other software-derived dose coefficients and those originally presented in ICRP publication 128. Dose coefficients computed with MIRDcalc and IDAC-Dose showed excellent overall agreement. The dose coefficients derived from other software and the dose coefficients promulgated in ICRP publication 128 both were in reasonable agreement with the dose coefficients computed with MIRDcalc. Future work should expand the scope of the validation to include personalized dosimetry calculations.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Carter LM, Ocampo Ramos JC, Olguin EA, et al. MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals. J Nucl Med. 2023. PMID: 37268423. doi:10.2967/jnumed.122.264230

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。